# EMFLAZA
> **NDA208684** · New Drug Application · Sponsor: PTC THERAP · Approved 2017-02-09
## Drug
- **FDA Application Number:** NDA208684
- **Application type:** New Drug Application
- **Brand name:** EMFLAZA
- **Generic name:** DEFLAZACORT
- **Active ingredients:** DEFLAZACORT
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PTC THERAP
- **Manufacturer:** PTC Therapeutics, Inc.
- **First approval:** 2017-02-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208684)
---
*MORVS · CC0 1.0*